<DOC>
	<DOCNO>NCT02774408</DOCNO>
	<brief_summary>In 2-phase cross-over study investigator test hypothesis automate adjustment inspire oxygen combine use synchronized noninvasive SpO2-sensitive apnea-sensitive backup-ventilation ( S-NIPPV ) increase time within intend oxygen saturation range compare automate FiO2 adjustment alone .</brief_summary>
	<brief_title>Effects Automated Adjustment Inspired Oxygen With Combined Adaptive Mechanical Backup Ventilation Compared Automated Oxygen Adjustment Alone Preterm Infants With Intermittent Hypoxemic Events During Non-invasive Ventilatory Support</brief_title>
	<detailed_description>This study randomized-controlled clinical study cross-over design two treatment phase 24h duration ( 1 . Automated FiO2-adjustment ( SPO2C ) , 2. combine use automate FiO2-adjustment SpO2-sensitive/apnea-sensitive S-NIPPV ( SPO2C + BU ) , see Figures 1 2 ) . The investigator study two patient group premature infant depend type respiratory support study time : One group , infant CPAP study time , another group preterm infant already support nasopharyngeal IPPV study time . Both study sufficiently power show significant treatment effect present . Study infant recruit neonatal ICU child 's hospital , University Ulm neonatal ICU , University Munich . Both NICU team participate previously clinical trial investigate new mode mechanical ventilation use automated ventilation adjustment target population . Randomization sequence two study phase carry use seal envelope . Infants change specific ventilator device approve clinical use neonate Germany ( Sophie®-Respirator , Stephan Medizintechnik GmbH , Gackenbach , Germany ) , capable automatically adjust FiO2 ( call `` SPO2C '' ) apply noninvasive backup-ventilation ( use noninvasive trigger device ( S-NIPPV ) non-synchronized nasal IPPV ( NIPPV ) base reading incorporate SpO2 monitoring device ( Masimo® Radical 7 , average time 2 sec ) . Synchronization NIPPV detection apnea achieve use Graseby capsule ( Stephan , Vio Healthcare Ltd , Ref . 103560103 ) , secure onto anterior abdominal wall near right costal margin . Infants CPAP ( first group ) expose first study phase ( SPO2C , SPO2C + BU , Figure 1 ) 24h switched alternate mode 24h . Infants , already nasal IPPV ( SIPPV NIPPV ) choose clinical team expose NIPPV standardized inflation rate 40 breaths/min ( nonsynchronized , seem current standard care accord available literature ) SPO2C , SPO2C plus synchronize BU ( start rate 80 inflations/min stepwise wean ) switch alternate mode 24h .</detailed_description>
	<criteria>1. postmenstrual age &lt; 34 wks GA study time ( &lt; 32 wks GA birth ) 2. nasal/nasopharyngeal CPAP nasal IMV / IPPV 3. least 4 desaturations ( SpO2 &lt; 80 % ) 8 hour period within 24h study use standard pulse oximeter incorporate NICU ( Masimo SET , Irvine , CA , average time 8 sec ; delay 10 ) 4. informed consent obtain parent legal guardian 1. postnatal age &lt; 96h ( exclude rapidly change condition early phase RDS avoid handle infant critical period IVH ) 2. congenital cyanotic heart disease 3. decision full treatment support 4 . Average FiO2 last 24h bevor active study phase &gt; 0.60 ( sick noninvasive ventilator support ) 5 . Congenital malformation lung diaphragm ( i.e . diaphragmatic hernia , congenital cystic lung disease ... ) 6 . Clinical evidence seizures 7 . Ongoing Sepsis hemodynamic compromise ( define CrP &gt; 20mg/l positive blood culture ( sepsis ) , requirement catecholamine ( hemodynamic compromise ) ) 8 . Need bloodtransfusion study time</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>34 Weeks</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>backup ventilation</keyword>
	<keyword>preterm infant</keyword>
	<keyword>functional residual capacity</keyword>
	<keyword>chronic lung disease</keyword>
</DOC>